Work

Why develop antidotes and reversal agents for non-vitamin K oral anticoagulants?

Year: 2015

Type: review

Source: Journal of Thrombosis and Thrombolysis

DOI: 10.1007/s11239-015-1296-1

Authors: Jeffrey B. Washam, Jonathan P. Piccini

Institutions: Duke Medical Center, Duke Clinical Research Institute

Language: English

Topic: Atrial Fibrillation Management and Outcomes

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: ARCA Biopharma, St. Jude Medical

OpenAlex ID: W1860308606

FWCI:

Cites: 40

Cited by:

Related to: 10